Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.

Michael Gnant; Florian Fitzal; Gabriel Rinnerthaler; Guenther G Steger; Sigrun Greil-Ressler; Marija Balic; Dietmar Heck; Raimund Jakesz; Josef Thaler; Daniel Egle; Diether Manfreda; Vesna Bjelic-Radisic; Ursula Wieder; Christian F Singer; Elisabeth Melbinger-Zeinitzer; Ferdinand Haslbauer; Paul Sevelda; Harald Trapl; Viktor Wette; Kerstin Wimmer; Simon Peter Gampenrieder; Rupert Bartsch; Stephanie Kacerovsky-Strobl; Christoph Suppan; Christine Brunner; Christine Deutschmann; Lidija Soelkner; Christian Fesl; Richard Greil

doi:10.1056/NEJMoa2104162

Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.

Michael Gnant, Florian Fitzal, Gabriel Rinnerthaler (Co-author), Guenther G Steger, Sigrun Greil-Ressler (Co-author), Marija Balic, Dietmar Heck, Raimund Jakesz, Josef Thaler, Daniel Egle, Diether Manfreda, Vesna Bjelic-Radisic, Ursula Wieder, Christian F Singer, Elisabeth Melbinger-Zeinitzer, Ferdinand Haslbauer, Paul Sevelda, Harald Trapl, Viktor Wette, Kerstin WimmerSimon Peter Gampenrieder (Co-author), Rupert Bartsch, Stephanie Kacerovsky-Strobl, Christoph Suppan, Christine Brunner, Christine Deutschmann, Lidija Soelkner, Christian Fesl, Richard Greil (Last author)

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

100 Citations (Web of Science)

Original language	English
Pages (from-to)	39-405
Journal	NEW ENGLAND JOURNAL OF MEDICINE
Volume	385
Issue number	5
DOIs	https://doi.org/10.1056/NEJMoa2104162
Publication status	Published - 2021

Keywords

ENDOCRINE THERAPY
AUSTRIAN BREAST
ANASTROZOLE
TAMOXIFEN
TRIAL
EXEMESTANE
LETROZOLE
BENEFIT
WOMEN

Access to Document

10.1056/NEJMoa2104162

Cite this

Gnant, M., Fitzal, F., Rinnerthaler, G., Steger, G. G., Greil-Ressler, S., Balic, M., Heck, D., Jakesz, R., Thaler, J., Egle, D., Manfreda, D., Bjelic-Radisic, V., Wieder, U., Singer, C. F., Melbinger-Zeinitzer, E., Haslbauer, F., Sevelda, P., Trapl, H., Wette, V., ... Greil, R. (2021). Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer. NEW ENGLAND JOURNAL OF MEDICINE , 385(5), 39-405. https://doi.org/10.1056/NEJMoa2104162

Gnant, Michael ; Fitzal, Florian ; Rinnerthaler, Gabriel et al. / Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer. In: NEW ENGLAND JOURNAL OF MEDICINE 2021 ; Vol. 385, No. 5. pp. 39-405.

@article{aeaf8b442e534a62bb0c56b3818b5089,

title = "Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.",

keywords = "ENDOCRINE THERAPY, AUSTRIAN BREAST, ANASTROZOLE, TAMOXIFEN, TRIAL, EXEMESTANE, LETROZOLE, BENEFIT, WOMEN",

author = "Michael Gnant and Florian Fitzal and Gabriel Rinnerthaler and Steger, {Guenther G} and Sigrun Greil-Ressler and Marija Balic and Dietmar Heck and Raimund Jakesz and Josef Thaler and Daniel Egle and Diether Manfreda and Vesna Bjelic-Radisic and Ursula Wieder and Singer, {Christian F} and Elisabeth Melbinger-Zeinitzer and Ferdinand Haslbauer and Paul Sevelda and Harald Trapl and Viktor Wette and Kerstin Wimmer and Gampenrieder, {Simon Peter} and Rupert Bartsch and Stephanie Kacerovsky-Strobl and Christoph Suppan and Christine Brunner and Christine Deutschmann and Lidija Soelkner and Christian Fesl and Richard Greil",

note = "Greil; Greil-Ressler; Gampenrieder; Rinnerthaler: the Department of Internal Medicine III and Salzburg Cancer Research Institute–Center for Clinical Cancer and Immunology Trials, Paracelsus Medical University Salzburg, Salzburg",

year = "2021",

doi = "10.1056/NEJMoa2104162",

language = "English",

volume = "385",

pages = "39--405",

journal = "NEW ENGLAND JOURNAL OF MEDICINE ",

issn = "0028-4793",

publisher = "Massachusetts Medical Soc",

number = "5",

}

Gnant, M, Fitzal, F, Rinnerthaler, G, Steger, GG, Greil-Ressler, S, Balic, M, Heck, D, Jakesz, R, Thaler, J, Egle, D, Manfreda, D, Bjelic-Radisic, V, Wieder, U, Singer, CF, Melbinger-Zeinitzer, E, Haslbauer, F, Sevelda, P, Trapl, H, Wette, V, Wimmer, K, Gampenrieder, SP, Bartsch, R, Kacerovsky-Strobl, S, Suppan, C, Brunner, C, Deutschmann, C, Soelkner, L, Fesl, C & Greil, R 2021, 'Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.', NEW ENGLAND JOURNAL OF MEDICINE , vol. 385, no. 5, pp. 39-405. https://doi.org/10.1056/NEJMoa2104162

Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer. / Gnant, Michael; Fitzal, Florian; Rinnerthaler, Gabriel (Co-author) et al.
In: NEW ENGLAND JOURNAL OF MEDICINE , Vol. 385, No. 5, 2021, p. 39-405.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.

AU - Gnant, Michael

AU - Fitzal, Florian

AU - Rinnerthaler, Gabriel

AU - Steger, Guenther G

AU - Greil-Ressler, Sigrun

AU - Balic, Marija

AU - Heck, Dietmar

AU - Jakesz, Raimund

AU - Thaler, Josef

AU - Egle, Daniel

AU - Manfreda, Diether

AU - Bjelic-Radisic, Vesna

AU - Wieder, Ursula

AU - Singer, Christian F

AU - Melbinger-Zeinitzer, Elisabeth

AU - Haslbauer, Ferdinand

AU - Sevelda, Paul

AU - Trapl, Harald

AU - Wette, Viktor

AU - Wimmer, Kerstin

AU - Gampenrieder, Simon Peter

AU - Bartsch, Rupert

AU - Kacerovsky-Strobl, Stephanie

AU - Suppan, Christoph

AU - Brunner, Christine

AU - Deutschmann, Christine

AU - Soelkner, Lidija

AU - Fesl, Christian

AU - Greil, Richard

N1 - Greil; Greil-Ressler; Gampenrieder; Rinnerthaler: the Department of Internal Medicine III and Salzburg Cancer Research Institute–Center for Clinical Cancer and Immunology Trials, Paracelsus Medical University Salzburg, Salzburg

PY - 2021

Y1 - 2021

KW - ENDOCRINE THERAPY

KW - AUSTRIAN BREAST

KW - ANASTROZOLE

KW - TAMOXIFEN

KW - TRIAL

KW - EXEMESTANE

KW - LETROZOLE

KW - BENEFIT

KW - WOMEN

U2 - 10.1056/NEJMoa2104162

DO - 10.1056/NEJMoa2104162

M3 - Original Article

C2 - 34320285

SN - 0028-4793

VL - 385

SP - 39

EP - 405

JO - NEW ENGLAND JOURNAL OF MEDICINE

JF - NEW ENGLAND JOURNAL OF MEDICINE

IS - 5

ER -

Gnant M, Fitzal F, Rinnerthaler G, Steger GG, Greil-Ressler S, Balic M et al. Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer. NEW ENGLAND JOURNAL OF MEDICINE . 2021;385(5):39-405. doi: 10.1056/NEJMoa2104162